CPRT vs TRI
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
CPRT · Copart$31.95 ▼ 1.63%
TRI · Thomson Reuters$112.57 ▼ 4.69%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- CPRT -22.8%
- TRI -14.8%
Head to head
| Metric | CPRT | TRI |
|---|---|---|
| Price | $31.95 | $112.57 |
| Change today | ▼ 1.63% | ▼ 4.69% |
| Market cap | $29.60B | $48.79B |
| Return, 3 months | +8.0% | +8.5% |
| Return, year to date | -18.4% | -12.8% |
| Return, 1 year | -21.1% | -16.1% |
| P/E (TTM) | 20.6 | 31.1 |
| P/B | 3.3 | 4.3 |
| P/E percentile vs own 5y | 9th | 45th |
| Dividend yield | – | 2.29% |
| Revenue growth (YoY, latest qtr) | +2.4% | +9.5% |
| Net profit growth (YoY) | -17.3% | +43.1% |
| Gross margin | 44.7% | 75.7% |
| Operating margin | 35.4% | 27.7% |
| Net margin | 31.8% | 21.2% |
| Return on equity | 16.2% | 14.0% |
| Analyst target vs. price | +17.9% | +11.1% |
| Analyst buy share | 57% | 67% |
| RSI (14) | 65 | 51 |
| 30-day volatility | 38.1% | 51.1% |
| Max drawdown, 1 year | -40.5% | -51.9% |
| Trend read | Leaning bullish | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- TRI is the largest of the group by market value.
- TRI has returned the most over the past year.
- CPRT carries the lowest trailing P/E.
- TRI is growing revenue fastest.
- CPRT keeps the most profit per dollar of sales.
- CPRT has been the calmest stock over the last 30 days.